MIS Pedicle Screw Market Size, Share and Trends Analysis | Global | 2025-2031 | MedCore

The global MIS pedicle screw market was valued at over $1.3 billion in 2024. This is expected to increase over the forecast period at a CAGR of 6.3% to reach over $2 billion.

The full report suite on the global market for MIS pedicle screws includes market analysis complete with units sold, ASP and market value. This market analysis includes the percutaneous cannulated, retractor cannulated and retractor non-cannulated pedicle screw segments.

This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

MARKET DATA INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031, and Historical Data to 2024
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

GLOBAL MIS PEDICLE SCREW MARKET TRENDS

• One of the most important market limiters for the MIS pedicle screw market is surgical complexity.
• MIS surgeries are relatively new compared to open traditional spine surgeries.
• There is a need for more education for surgeons to be comfortable using these in their surgeries.
• Learning of these techniques requires time and training, which could be expensive.
• As a result, it would be one of the biggest limiters, especially in less developed countries.

Global Market Share Insights

1. 1. Medtronic

• Top competitor in the global MIS pedicle screw market in 2024.
• Strength due to Minimal Access Spine Technologies (MAST) systems.
• Leading competitor in North America, Western Europe and Rest of the World.

2. 2. Globus Medical / NuVasive

• Second-largest share of the global MIS pedicle screw market in 2024.
• Ranked second in both North American and Rest of World markets.
• Notable presence in Western Europe.

3. 3. Stryker

• Third-leading competitor in 2024.
• Sizeable share in the Rest of World segment.
• Third-largest share in both North America and Western Europe.

Research Scope Summary

Regions

• North America (Canada, United States)
• Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
• Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
• Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
• Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
• Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
• Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2024

Forecast Period: 2025-2031

Historical Data: 2021-2023

Quantitative Data

• Procedure Numbers
• Market Size
• Market Shares
• Market Forecasts
• Market Growth Rates
• Units Sold
• Average Selling Prices

Qualitative Data

• Market Growth Trends
• Market Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles
• Product Portfolios
• FDA Recalls
• Disruptive Technologies
• Disease Overviews

Data Sources

• Primary Interviews with Industry Leaders
• Government Physician Data
• Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database